Original Publication Date: 1 March, 2016
Publication / Source: Melanoma Management
Authors: Upendra P Hegde, Bijay Mukherji & Jane M Grant-Kels
Melanoma incidence is rapidly increasing in the geriatric population making it a major public health issue [1,2]. Healthcare cost analysis of cancer treatment suggests a significant economic burden related to metastatic melanoma treatment of the elderly patient . Larger studies have shown that age is an independent negative prognostic factor of survival in older subjects diagnosed with cutaneous melanoma . Melanoma is an immunogenic tumor and anti-melanoma immunity plays an important role in shaping its course as well as the rising incidence noted in the geriatric population .